Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Feb 2021. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 64521000001112 | Trixeo Aerosphere 5micrograms/dose / 7.2micrograms/dose / 160micrograms/dose pressurised inhaler (AstraZeneca UK Ltd) 120 dose | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 64541000001119 | Trixeo Aerosphere 5micrograms/dose / 7.2micrograms/dose / 160micrograms/dose pressurised inhaler (AstraZeneca UK Ltd) 120 dose (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Trixeo Aerosphere 5micrograms/dose / 7.2micrograms/dose / 160micrograms/dose pressurised inhaler (AstraZeneca UK Ltd) 120 dose | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
| Trixeo Aerosphere 5micrograms/dose / 7.2micrograms/dose / 160micrograms/dose pressurised inhaler (AstraZeneca UK Ltd) 120 dose | Has specific active ingredient | Formoterol fumarate dihydrate | true | Inferred relationship | Existential restriction modifier | ||
| Trixeo Aerosphere 5micrograms/dose / 7.2micrograms/dose / 160micrograms/dose pressurised inhaler (AstraZeneca UK Ltd) 120 dose | Has NHS dm+d (dictionary of medicines and devices) freeness indicator | CFC free | true | Inferred relationship | Existential restriction modifier | ||
| Trixeo Aerosphere 5micrograms/dose / 7.2micrograms/dose / 160micrograms/dose pressurised inhaler (AstraZeneca UK Ltd) 120 dose | Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator | NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none | true | Inferred relationship | Existential restriction modifier | ||
| Trixeo Aerosphere 5micrograms/dose / 7.2micrograms/dose / 160micrograms/dose pressurised inhaler (AstraZeneca UK Ltd) 120 dose | VMP prescribing status (attribute) | Never valid to prescribe as a VMP | true | Inferred relationship | Existential restriction modifier | ||
| Trixeo Aerosphere 5micrograms/dose / 7.2micrograms/dose / 160micrograms/dose pressurised inhaler (AstraZeneca UK Ltd) 120 dose | Has dispensed dose form | Pressurised inhalation | true | Inferred relationship | Existential restriction modifier | ||
| Trixeo Aerosphere 5micrograms/dose / 7.2micrograms/dose / 160micrograms/dose pressurised inhaler (AstraZeneca UK Ltd) 120 dose | Has NHS dm+d (dictionary of medicines and devices) basis of strength substance | Glycopyrronium | true | Inferred relationship | Existential restriction modifier | ||
| Trixeo Aerosphere 5micrograms/dose / 7.2micrograms/dose / 160micrograms/dose pressurised inhaler (AstraZeneca UK Ltd) 120 dose | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Trixeo Aerosphere 5micrograms/dose / 7.2micrograms/dose / 160micrograms/dose pressurised inhaler (AstraZeneca UK Ltd) 120 dose | Legal category | Prescription only medicine - legal category (qualifier value) | true | Inferred relationship | Existential restriction modifier | ||
| Trixeo Aerosphere 5micrograms/dose / 7.2micrograms/dose / 160micrograms/dose pressurised inhaler (AstraZeneca UK Ltd) 120 dose | Is a | Generic Trixeo Aerosphere 5micrograms/dose / 7.2micrograms/dose / 160micrograms/dose inhaler CFC free 120 dose | true | Inferred relationship | Existential restriction modifier | ||
| Trixeo Aerosphere 5micrograms/dose / 7.2micrograms/dose / 160micrograms/dose pressurised inhaler (AstraZeneca UK Ltd) 120 dose | Discontinued indicator | Never discontinued | true | Inferred relationship | Existential restriction modifier | ||
| Trixeo Aerosphere 5micrograms/dose / 7.2micrograms/dose / 160micrograms/dose pressurised inhaler (AstraZeneca UK Ltd) 120 dose | Is a | Actual medicinal product pack | true | Inferred relationship | Existential restriction modifier | ||
| Trixeo Aerosphere 5micrograms/dose / 7.2micrograms/dose / 160micrograms/dose pressurised inhaler (AstraZeneca UK Ltd) 120 dose | Has AMP | Trixeo Aerosphere 5micrograms/dose / 7.2micrograms/dose / 160micrograms/dose pressurised inhaler (AstraZeneca UK Ltd) | true | Inferred relationship | Existential restriction modifier | ||
| Trixeo Aerosphere 5micrograms/dose / 7.2micrograms/dose / 160micrograms/dose pressurised inhaler (AstraZeneca UK Ltd) 120 dose | Has specific active ingredient | Budesonide | true | Inferred relationship | Existential restriction modifier | ||
| Trixeo Aerosphere 5micrograms/dose / 7.2micrograms/dose / 160micrograms/dose pressurised inhaler (AstraZeneca UK Ltd) 120 dose | Has excipient | Excipient not declared | true | Inferred relationship | Existential restriction modifier | ||
| Trixeo Aerosphere 5micrograms/dose / 7.2micrograms/dose / 160micrograms/dose pressurised inhaler (AstraZeneca UK Ltd) 120 dose | Has specific active ingredient | Glycopyrronium bromide | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR